PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.07%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.07%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-6.07%
Negative EBIT growth while JHX is at 386.17%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-6.07%
Negative operating income growth while JHX is at 123.19%. Joel Greenblatt would press for urgent turnaround measures.
48.41%
Net income growth 1.25-1.5x JHX's 43.58%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
60.00%
EPS growth 1.25-1.5x JHX's 50.00%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
60.00%
Diluted EPS growth 1.25-1.5x JHX's 51.06%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
-7.24%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-7.24%
Reduced diluted shares while JHX is at 0.12%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.23%
10Y revenue/share CAGR under 50% of JHX's 117.83%. Michael Burry would suspect a lasting competitive disadvantage.
14.23%
5Y revenue/share CAGR under 50% of JHX's 48.10%. Michael Burry would suspect a significant competitive gap or product weakness.
14.23%
Positive 3Y CAGR while JHX is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.